109 related articles for article (PubMed ID: 4327021)
1. Synthesis of (5-valine,7-N-methylalanine)-angiotensin II, a hypertensive peptide.
Andreatta RH; Scheraga HA
J Med Chem; 1971 Jun; 14(6):489-92. PubMed ID: 4327021
[No Abstract] [Full Text] [Related]
2. Alkylating analogs of peptide hormones. 2. Synthesis and properties of p-(N,N-bis(2-chloroethyl)amino)phenylbutyryl derivatives of angiotensin II.
Paiva TB; Paiva AC; Freer RJ; Stewart JM
J Med Chem; 1972 Jan; 15(1):6-8. PubMed ID: 4331919
[No Abstract] [Full Text] [Related]
3. New specific angiotensin antagonists. (8-Valine)-, (8-isoleucine)-, and chlorambucil-des-1-aspartic,8-valine-angiotensins I.
Paiva AC; Nouaihetas VL; Miyamoto ME; Mendes GB; Paiva TB
J Med Chem; 1973 Jan; 16(1):6-9. PubMed ID: 4344926
[No Abstract] [Full Text] [Related]
4. Alkylating analogs of peptide hormones. 1. Synthesis and properties of p-(N,N-)-bis(2-chloroethyl)amino)phenylbutyryl derivatives of bradykinin and bradykinin potentiating factor.
Freer RJ; Stewart JM
J Med Chem; 1972 Jan; 15(1):1-5. PubMed ID: 4331917
[No Abstract] [Full Text] [Related]
5. Synthesis of angiotensin II antagonists by incorporating alpha-methylalanine or O-methylthreonine residues in angiotension II analogues.
Khosla MC; Muñoz-Ramírez H; Hall MM; Khairallah PA; Bumpus FM
J Med Chem; 1977 Aug; 20(8):1051-5. PubMed ID: 894674
[No Abstract] [Full Text] [Related]
6. Analogs of angiotensin II. II. Mechanism of receptor interaction.
Khairallah PA; Toth A; Bumpus FM
J Med Chem; 1970 Mar; 13(2):181-4. PubMed ID: 4313898
[No Abstract] [Full Text] [Related]
7. A new class of angiotensin inhibitors: N-methylphenylalanine analogs.
Peña C; Stewart JM; Goodfriend TC
Life Sci; 1974 Apr; 14(7):1331-6. PubMed ID: 4363010
[No Abstract] [Full Text] [Related]
8. Synthesis of octanoyl[8-leucyl]angiotensin II, a lipophilic angiotensin antagonist.
Paiva AC; Nouailhetas VL; Paiva TB
J Med Chem; 1977 Jul; 20(7):898-901. PubMed ID: 874965
[TBL] [Abstract][Full Text] [Related]
9. Angiotensin II analogs. 11. Further studies on des-aspartyl-angiotensin II.
Jorgensen EC; Kiraly-Olah IC; Lee TC; Windridge GC
J Med Chem; 1974 Mar; 17(3):323-6. PubMed ID: 4359545
[No Abstract] [Full Text] [Related]
10. Angiotensin-like and antagonistic activities of N-terminal modified (8-leucine)angiotensin II peptides.
Paiva TB; Goissis G; Juliano L; Miyamoto ME; Paiva AC
J Med Chem; 1974 Feb; 17(2):239-41. PubMed ID: 4358432
[No Abstract] [Full Text] [Related]
11. Angiotensin II. Synthesis and biological activity of 6-(1-methylhistidine) and 6-(3-methylhistidine) analogs.
Needleman P; Marshall GR; Rivier J
J Med Chem; 1973 Sep; 16(9):968-70. PubMed ID: 4355510
[No Abstract] [Full Text] [Related]
12. 1,8-disubstituted analogues of (Ile5) and (Val5)angiotensin II: difference in potency and specificity of angiotensin II-antagonistic activity.
Schoelkens BA; Wissmann H; Lindner E; Geiger R
Hoppe Seylers Z Physiol Chem; 1976 Jun; 357(6):825-38. PubMed ID: 955577
[TBL] [Abstract][Full Text] [Related]
13. Further studies on lidoflazine (R-7904).
Türker RK; Kayaalp SO; Ozer A
Arzneimittelforschung; 1968 Sep; 18(9):1209-12. PubMed ID: 4387885
[No Abstract] [Full Text] [Related]
14. Some aspects of the pharmacology of valyl-beta-(pyrazolyl-3)-L-alanyl6-angiotensin II.
Hageman WE; Hofmann K; Ertel RJ; Buckley JP
J Pharmacol Exp Ther; 1969 Aug; 168(2):295-302. PubMed ID: 4308499
[No Abstract] [Full Text] [Related]
15. Bradykinin potentiating peptide PCA-Lys-Trp-Ala-Pro. An inhibitor of the pulmonary inactivation of bradykinin and conversion of angiotensin I to II.
Stewart JM; Ferreira SH; Greene LJ
Biochem Pharmacol; 1971 Jul; 20(7):1557-67. PubMed ID: 4355304
[No Abstract] [Full Text] [Related]
16. Effect of lipophilic character on the biological activity of synthetic angiotensin peptides.
Nouailhetas VL; Nakaie CR; Juliano L; Paiva AC
Biochem J; 1977 Sep; 165(3):547-51. PubMed ID: 921765
[TBL] [Abstract][Full Text] [Related]
17. Angiotensin II analogs. II. Cyclo-(-Val-Tyr-Ile-His-Pro-Phe-).
Jorgensen EC; Patton W
J Med Chem; 1969 Sep; 12(5):935-6. PubMed ID: 4309508
[No Abstract] [Full Text] [Related]
18. Synthesis of a proposed pepsitensin.
Paiva AC; Paiva TB; Miyamoto ME
J Med Chem; 1973 Mar; 16(3):280-1. PubMed ID: 4738981
[No Abstract] [Full Text] [Related]
19. The effect of pH on tachyphylaxis to angiotensin peptides in the isolated guinea pig ileum and rat uterus.
Paiva TB; Juliano L; Nouailhetas VL; Paiva AC
Eur J Pharmacol; 1974 Feb; 25(2):191-6. PubMed ID: 4373250
[No Abstract] [Full Text] [Related]
20. Pharmacological activity of angiotensin-II modified by tyrosine sulfation.
Hagiwara M; Ohuchi E; Hongo K; Oki M; Wada K; Morikawa T; Kobashi K
Jpn J Pharmacol; 1990 Mar; 52(3):493-5. PubMed ID: 2332941
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
